Trial intelligence / Profile preview

Phase 2 open-label pexidartinib study in adults with tenosynovial giant cell tumor in Japan

jRCT2041200074Phase 2Completed

Sponsor

Daiichi Sankyo Co., Ltd.

Start

Mar 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1